Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H19O4P |
| Molecular Weight | 210.2078 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOP(O)(=O)OCCCC
InChI
InChIKey=JYFHYPJRHGVZDY-UHFFFAOYSA-N
InChI=1S/C8H19O4P/c1-3-5-7-11-13(9,10)12-8-6-4-2/h3-8H2,1-2H3,(H,9,10)
Dibutyl phosphate is be used as a precursor for antistatics, a mold release agent in polyurethane applications, and a non-volatile acidic catalyst in organic media. It is also used in many industrial applications as a surfactant because of its exceptional properties of wetting, emulsification, lubrication, coupling activity and detergency. Biologically Dibutyl phosphate is used as a diagnostic urine marker for exposure to certain toxic alkyl-phosphate compounds found in insecticides and industrial lubricants.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Improved determination of tributyl phosphate degradation products (mono- and dibutyl phosphates) by ion chromatography. | 2001 Jun 22 |
|
| Synthesis of glycosyl phosphates from 1,2-orthoesters and application to in situ glycosylation reactions. | 2006 Apr 27 |
|
| Multivariate curve resolution applied to infrared reflection measurements of soil contaminated with an organophosphorus analyte. | 2006 Jul |
|
| Dissociative electron attachment to phosphoric acid esters: the direct mechanism for single strand breaks in DNA. | 2006 Jul 7 |
Sample Use Guides
Male Sprague Dawley rats were fasted for 24 hours and killed by decapitation 60 minutes after the injection of 1 mmol/ kg dibutyl phosphate dissolved in 1 ml/kg of corn oil. Livers were rapidly excised and processed to produce microsomal and lysosomal fractions. Analysis of beta-glucuronidase from the Golgi and lysosomal fractions imply that microsomal beta-glucuronidase undergoes extensive modification of the oligosaccharide moieties by terminal glycosyltransferases at the trans-Golgi when it is destined for secretion into serum in response to treatment with an organophosphate compound.
Route of Administration:
Parenteral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID3040728
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY | |||
|
107-66-4
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY | |||
|
203-509-8
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY | |||
|
C065087
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY | |||
|
2513
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY | |||
|
7881
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY | |||
|
0072NN74TN
Created by
admin on Fri Dec 15 17:46:38 GMT 2023 , Edited by admin on Fri Dec 15 17:46:38 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
